Are Participant Dropouts Impacting Your Clinical Trial Success?
30% of
patients drop
out of trials
Leading to missed endpoints and delayed timelines.1
$19,000 for
each
replacement
The true cost of recruitment and re-enrollment.1
80% of trials
delayed by
~one month
Many delayed significantly longer1
YPrime’s clinical trial technology platform offers patient engagement features across eConsent and eCOA, leveraging user-friendly design, personalization, and behavioral science to drive patient retention and adherence.

Participant Engagement
with Certainty—We’ve
Got You Covered.
Before they are trial participants, people bring questions, concerns, and real-life responsibilities into every study. YPrime’s participant engagement strategy is built on this understanding.
Through human-centric design and research-informed decision-making, we focus on reducing participant burden and uncertainty by delivering clear, relevant information at every stage of the trial. By integrating engagement directly into the clinical trial workflow, studies fit more naturally into participants’ daily routines, supporting adherence, retention, and overall trial performance.
Let YPrime Help You Run Your Clinical Trials with Certainty.
When we work together, you gain confidence that your clinical trial technology supports participants, sites, and sponsors alike. YPrim eConsent, IRT, and eCOA enables informed participation, operational consistency, and inspection-ready execution across global trials.
Explore Insights from Our Experts.
Gain practical perspectives on participant engagement, clinical trial design, and technology-enabled execution—so you can make confident decisions throughout the study lifecycle.

